|
Leucovorin Injection
|
|
Wellcovorin Injection
|
Leucovorin Injection Clinical Trials
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms
- High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00004150 - Active, not recruiting
stage III colon cancer; adenocarcinoma of the colon; mucinous adenocarcinoma of the colon
- A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients with Pneumocystis carinii Pneumonia and Serious Intolerance to Approved Therapies
ClinicalTrials.gov Identifier: NCT00001016 - Active, not recruiting
Pneumonia, Pneumocystis carinii; HIV Infections
- A study of capecitabine in combo w/ XELOX vs fluorouracil/leucovorin w/ oxaliplatin (FOLFOX4) as treatment for pts w/ metastatic colorectal cancer, who have received prior treatment w/ CPT-11 in combo w/ fluorouracil/leucovorin
ClinicalTrials.gov Identifier: NCT00069108 - Active, not recruiting
Colorectal Cancer; Metastases
- Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
ClinicalTrials.gov Identifier: NCT00004317 - Recruiting
Toxoplasmosis
- Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
ClinicalTrials.gov Identifier: NCT00091312 - Active, not recruiting
stage II colon cancer; adenocarcinoma of the colon
- Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00004233 - Active, not recruiting
Gastric Cancer; Esophageal Cancer; Adenocarcinoma of the Esophagus
- Capecitabine Compared With Fluorouracil Plus Leucovorin in Treating Patients Who Have Undergone Surgery for Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00009737 - Active, not recruiting
stage III colon cancer
- Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00075738 - Active, not recruiting
stage IV esophageal cancer; recurrent esophageal cancer
- Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
ClinicalTrials.gov Identifier: NCT00103103 - Active, not recruiting
recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00005608 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00082797 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
ClinicalTrials.gov Identifier: NCT00085163 - Active, not recruiting
adenocarcinoma of the colon; stage III colon cancer
- Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
ClinicalTrials.gov Identifier: NCT00082706 - Recruiting
Bladder Cancer; Urethral Cancer
- Trial of Cetuximab, Bevacizumab and 5FU/Leucovorin Versus Oxaliplatin, Bevacizumab and 5FU/Leucovorin in Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00252564 - Recruiting
Metastatic Colorectal Cancer
- Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
ClinicalTrials.gov Identifier: NCT00507091 - Active, not recruiting
Metastatic; Colorectal; Adenocarcinoma
- Penile Injection Anxiety
ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00270543 - Not yet recruiting
Stomach Neoplasms
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00080951 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
- Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
Myocardial Infarction
- Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
ClinicalTrials.gov Identifier: NCT00005586 - Active, not recruiting
stage II colon cancer; stage III colon cancer; stage II rectal cancer; stage III rectal cancer
- A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
- Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00096278 - Active, not recruiting
adenocarcinoma of the colon; stage II colon cancer; stage III colon cancer
- Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
- Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00026273 - Active, not recruiting
adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; adenocarcinoma of the colon
- Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00016952 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
- Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00004931 - Active, not recruiting
stage III colon cancer; stage II colon cancer
- Flavopiridol, Oxaliplatin, Fluorouracil, and Leucovorin in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00080990 - Recruiting
unspecified adult solid tumor, protocol specific
- Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00075595 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
- Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00002842 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
- Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00070213 - Recruiting
Colon Cancer; Quality of Life; Rectal Cancer
- Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00072553 - Active, not recruiting
Stage IV rectal cancer; stage IV colon cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00062426 - Active, not recruiting
adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
- Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00016198 - Active, not recruiting
recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
- Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00098982 - Active, not recruiting
stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
- Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00004252 - Active, not recruiting
recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; adenocarcinoma of the colon
- Combination Chemotherapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003331 - Active, not recruiting
Cancer
- Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
ClinicalTrials.gov Identifier: NCT00077233 - Active, not recruiting
adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; recurrent rectal cancer; stage IV colon cancer; ...
- Combination Chemotherapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003956 - Active, not recruiting
Cancer
- Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
Myelodysplastic Syndromes
- Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00004885 - Active, not recruiting
recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; ...
- Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer
ClinicalTrials.gov Identifier: NCT00425152 - Active, not recruiting
Colorectal Cancer
- Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00002547 - Active, not recruiting
Leukemia
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Advanced Small Bowel Adenocarcinoma (Cancer)
ClinicalTrials.gov Identifier: NCT00081198 - Not yet recruiting
small intestine adenocarcinoma
- Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
- Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil, Leucovorin and Avastin
ClinicalTrials.gov Identifier: NCT00507585 - Recruiting
Liver Cancer
- Capecitabine in Combination with Oxaliplatin (XELOX) vs. Fluorouracil/Leucovorin as Adjuvant Therapy for Patients who have Undergone Surgery for Colon Carcinoma
ClinicalTrials.gov Identifier: NCT00069121 - Active, not recruiting
Colorectal Cancer
- Adverse Drug Reactions of Different Brands of Ceftazidime Injection
ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
Infection
- Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
ClinicalTrials.gov Identifier: NCT00176774 - Active, not recruiting
Colorectal Carcinoma
- Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
Pain
- Validation of Self-Reported Needle Sharing Among Injection Drug Users
ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
Viral Infection
- EPC by Intracoronary Injection in Patients With Chronic Stable Angina
ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
Coronary Artery Disease
- Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
Lymphoma; Leukemia
- A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
- Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC
ClinicalTrials.gov Identifier: NCT00313859 - Recruiting
Colorectal Cancer; Metastasis
- Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00168155 - Active, not recruiting
Colorectal Adenocarcinoma; Liver Metastases
- Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
ClinicalTrials.gov Identifier: NCT00005641 - Active, not recruiting
Leukemia; Multiple Myeloma
- Safety/Efficacy of Camptosar, Avastin, & 5-FU/LV 2-Schedules w/ Celebrex/Placebo as Colorectal Cancer Initial Treatment
ClinicalTrials.gov Identifier: NCT00101686 - Active, not recruiting
Colorectal Cancer; Metastases
- The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
- Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
Type A Botulinum Toxin; Tennis Elbow
- Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)
ClinicalTrials.gov Identifier: NCT00387387 - Recruiting
Colorectal Cancer
- Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
Myocardial Infarction; Heart Failure, Congestive
- Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
Psoriasis
- A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
Schizophrenia
- IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
Glaucoma; Intraocular Pressure
- Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
HIV Infections; Hepatitis C
- Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
Neovascular Glaucoma
- A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
HCV Negative Status; HCV Risk Behavior
- Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
ClinicalTrials.gov Identifier: NCT00217737 - Recruiting
Colorectal Cancer
- A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients with Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00037089 - Active, not recruiting
Esophageal Neoplasm
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
ClinicalTrials.gov Identifier: NCT00005988 - Active, not recruiting
Leukemia; Lymphoma; Multiple Myeloma
- A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
Recovery Following Partial Medial Meniscectomy
- Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
- Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00005036 - Active, not recruiting
Colon Cancer; Rectal Cancer
- Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
Colorectal Neoplasms
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
- Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00004913 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00098787 - Recruiting
recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; adenocarcinoma of the colon; ...
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
recurrent adult acute lymphoblastic leukemia
- Combination Chemotherapy In Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003925 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00043121 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00514020 - Recruiting
Gastric Cancer
- Methotrexate, Leucovorin, Rituximab, and Highly Active Antiretroviral Therapy in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
ClinicalTrials.gov Identifier: NCT00304044 - Recruiting
Lymphoma; Neurotoxicity
- Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00055822 - Active, not recruiting
Colon Cancer; Rectal Cancer
- Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00007878 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005596 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia
- A 2x2 (4-way) study of capecitabine in combo w/ oxaliplatin (XELOX) w/ or w/out bevacizumab vs. fluorouracil/leucovorin w/ oxaliplatin (FOLFOX-4) w/ or w/out bevacizumab as first-line treatment for pts w/ metastatic colorectal cancer
ClinicalTrials.gov Identifier: NCT00069095 - Active, not recruiting
Metastatic Colorectal Cancer
- Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
Breast Cancer
- Vitamin K Injections for the Treatment of Painful Menstruation
ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
Dysmenorrhea
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
ClinicalTrials.gov Identifier: NCT00524186 - Recruiting
Esophageal Cancer; Gastric Cancer
- Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment
ClinicalTrials.gov Identifier: NCT00449137 - Recruiting
Colorectal Cancer
- Oxaliplatin + 5-FluoroUracil/LeucoVorin(5-FU/LV) (FOLFOX4) vs Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients
ClinicalTrials.gov Identifier: NCT00471965 - Recruiting
Carcinoma, Hepatocellular
- Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
ClinicalTrials.gov Identifier: NCT00537121 - Recruiting
Esophageal Cancer; Gastric Cancer; Liver Cancer
- Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Patients With Progressive Metastatic or Unresectable Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00138177 - Recruiting
recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
- A New Agent DAVANAT in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00388700 - Recruiting
Colorectal Cancer
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00501410 - Recruiting
Colorectal Cancer
- Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases from Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00008294 - Active, not recruiting
Colon Cancer; liver metastases; Rectal Cancer
- Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00002955 - Active, not recruiting
stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002816 - Active, not recruiting
Quality of Life; recurrent childhood acute lymphoblastic leukemia
- Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
Melanoma
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
